Melatonin Boosts DNA Repair in Night Shift Workers

Scientists just found that a bedtime supplement most people already have in their medicine cabinet might protect night shift workers from hidden cellular damage.

A clinical trial published in Occupational & Environmental Medicine reveals that melatonin supplements boosted DNA repair activity by 80% in night shift workers during their daytime sleep. The finding offers hope for the 20 million Americans who work overnight and face higher risks of certain cancers.

The study involved 40 healthcare workers who regularly worked night shifts. Half took 3 mg of melatonin daily for four weeks, while the other half received a placebo. All participants took their pill about an hour before their daytime sleep.

Researchers measured a specific marker in urine that shows how well the body repairs oxidative DNA damage. This type of cellular wear and tear happens naturally but can accumulate when repair systems don't work properly.

The results were striking. Workers taking melatonin showed dramatically higher repair activity during their post-shift sleep compared to those on the placebo. Their bodies appeared to be fixing DNA damage more effectively, right when they needed it most.

Here's why that matters. When people work overnight, their natural melatonin production gets suppressed. This hormone normally rises in darkness and does more than just make you sleepy. It also appears to help coordinate the body's repair processes during rest.

Night shift work has been classified as probably carcinogenic by the International Agency for Research on Cancer. The disruption to circadian rhythms, hormone signaling, and DNA repair may all play a role in this increased risk.

The Bright Side

This small study opens the door to a remarkably simple intervention. Melatonin supplements are inexpensive, widely available, and already used by millions for sleep support.

The researchers are careful to note this doesn't prove melatonin prevents cancer in night workers. The study was short, involved only 40 people, and measured a biomarker rather than actual health outcomes. Larger, longer trials are needed.

But the biological logic is compelling. If melatonin can restore some of the repair signaling that night work disrupts, it might help reduce accumulated cellular damage over time. That could make a real difference for nurses, emergency responders, factory workers, and others who keep society running after dark.

The research team is calling for bigger studies with different doses and longer follow-up periods. For now, though, night shift workers have a scientifically grounded reason to talk with their doctors about whether melatonin might help protect their health while they protect ours.